english
stringlengths 2
1.37k
|
---|
Do not use Bondronat:
|
The haemoglobin concentration aimed for is between 10 and 12 g/ dl (6.2 - 7.5 mmol/ l), except in paediatric patients in whom the haemoglobin concentration should be between 9.5 and 11 g/ dl (5.9 - 6.8 mmol/ l).
|
EXPIRY DATE
|
Keep out of the reach and sight of children.
|
Flushing
|
If you take more Circadin than you should If you have accidentally taken too much of your medicine, contact your doctor or pharmacist as soon as possible.
|
Not all pack sizes may be marketed.
|
- pale skin, tiredness, or bruising, as these may indicate blood disorders caused by an imbalance
|
In clinical studies, patients with creatinine clearance of ≥ 45 ml/ min required no dose adjustments other than those recommended for all patients.
|
Tel: +34 – 94 481 83 00
|
6.
|
Very common Common Very common Common
|
You will therefore need regular blood tests to determine the correct daily dose.
|
10.
|
- breathlessness
|
Based on this analysis there were no cases in the vaccine group and 20 cases in the control group (Efficacy 100%; 97.9% CI:
|
Common: alterations in some laboratory blood tests (including decreased red blood cell count and increased values of some liver and kidney tests Uncommon: high calcium
|
Children (< 2 years): there are limited safety and efficacy data in children below the age of 2 years.
|
100 D-60318 Frankfurt/ Main Germany
|
1 injection needle (20 gauge) 1 hypodermic injection needle (27 gauge) 2 alcohol swabs.
|
Powder for concentrate for solution for injection or infusion.
|
GENERAL CLASSIFICATION FOR SUPPLY
|
30-60
|
Therefore, pioglitazone should not be administered to breast-feeding women.
|
Rare
|
4.1 Therapeutic indications
|
For toremifene, flucloxacillin and fusidic acid displacement interactions could not be excluded (no clinically relevant capturing interactions are expected).
|
Clinically significant laboratory abnormalities frequently (≥ 5%) occurred including increases in alkaline phosphatase; AST and bilirubin which were believed to be related to the underlying disease and not Caelyx.
|
Рачо Димчев 4 София 1000 тел.: + 359 2 9808482
|
Aranesp 300 micrograms solution for injection in a pre-filled syringe Darbepoetin alfa
|
Before you use Cerezyme.
|
Medicinal product subject to medical prescription.
|
CIALIS is contraindicated in patients who have loss of vision in one eye because of non-arteritic anterior ischemic optic neuropathy (NAION), regardless of whether this episode was in connection or not with previous PDE5 inhibitor exposure (see section 4.4).
|
APTIVUS soft capsules co-administered with low dose ritonavir should be taken with food (see section 5.2).
|
TRAY LID
|
Package size
|
These measures will help to protect the environment.
|
Medicinal product subject to medical prescription.
|
Store in a refrigerator (2°C to 8°C) For the convenience of the patient the product can be removed from such storage for one single period of maximum 1 month at room temperature (up to 25°C).
|
Luxembourg/ Luxemburg sanofi-aventis Belgium Tél/ Tel: +32 (0)2 710 54 00 (Belgique/ Belgien)
|
CT Arzneimittel GmbH Lengeder Straße 42a D-13407 Berlin Germany info@ct-arzneimittel. de
|
6.1 List of excipients
|
4.2 Posology and method of administration
|
A causal relationship has been evoked, although the mechanism of action has not been elucidated.
|
HBeAg positive (study 022): treatment with entecavir for up to 96 weeks (n = 354) resulted in cumulative response rates of 80% for HBV DNA < 300 copies/ ml by PCR, 87% for ALT normalisation, 31% for HBeAg seroconversion and 2% for HBsAg seroconversion (5% for HBsAg loss).
|
Reproduction is authorised provided the source is acknowledged.
|
The studies measured the effectiveness of the treatment by looking at how the liver damage had evolved after 48 weeks treatment (using a liver biopsy, when a sample of liver tissue is taken and examined under a microscope) as well as measuring other signs of the disease such as the levels of a liver enzyme (ALT) or viral DNA circulating in the blood of the patients.
|
The use of Cervarix should be in accordance with official recommendations.
|
level may become too high (hyperglycaemia).
|
There are no data in severe renal impairment.
|
OTHER SPECIAL WARNING(S), IF NECESSARY
|
The initial weekly or once every other week pediatric dose of Aranesp (µg/ week) can be determined by dividing the total weekly dose of r-HuEPO (IU/ week) by 240.
|
16.
|
BeneFIX should be started by a doctor who has experience in the treatment of haemophilia.
|
Κύπρος Takeda Global R & D Centre (Europe), Ηνω µένο Βασίλειο Τηλ: +44 (0)20 3116 8000
|
Treatment of postmenopausal osteoporosis in patients at risk of vitamin D insufficiency.
|
Maintenance phase:
|
• increased risk of death when administered to target a haemoglobin of 12 g/ dl (7.5 mmol/ l) in patients with active malignant disease receiving neither chemotherapy nor radiation therapy. ESAs are not indicated for use in this patient population.
|
13.
|
In a study to assess the effects of tadalafil on vision, no impairment of colour discrimination (blue/ green) was detected using the Farnsworth-Munsell 100-hue test.
|
167 chemotherapy to achieve haemoglobin concentrations less than 13 g/ dl, is unclear because few patients with these characteristics were included in the data reviewed.
|
How to take Aprovel 4.
|
Musculoskeletal and connective tissue disorders:
|
4 pre-filled syringes
|
32 Gastrointestinal disorders
|
Actraphane 50 Penfill
|
See section 4.4.
|
It may harm them, even
|
Chest pain
|
The recommended dose of ibandronic acid is 3 mg, administered as an intravenous injection over 15 - 30 seconds, every three months.
|
ADENURIC 80 mg film-coated tablets
|
Once weekly
|
In the prospectively defined primary analysis statistical significance was not reached at the primary efficacy endpoint at week 24.
|
EXPIRY DATE
|
Bisphosphonates, ATC code:
|
patients with active malignant disease receiving neither chemotherapy nor radiation therapy.
|
AREA 6
|
Mention to your doctor, nurse or pharmacist anything you are taking which you bought over the counter, without a prescription.
|
- If you are already pregnant, or think that you might be, talk to a doctor as soon as you can.
|
SPECIAL STORAGE CONDITIONS
|
Each pre-filled pen contains 300 micrograms of darbepoetin alfa in 0.6 ml (500 µg/ ml).
|
Each tablet contains:
|
9 (9) Common:
|
Immune system disorders
|
10 GLULISINE LISPRO GIR - mg/ kg/ min
|
3.
|
3.
|
Maintenance phase:
|
Treatment naïve patients The resistance profile in treatment-naïve patients has not been characterized.
|
12.
|
4.
|
No line listings are required – these can be provided in signal evaluation reports as necessary.
|
Haemoglobin variability should be addressed through dose management, with consideration for the haemoglobin target range of 10 g/ dl (6.2 mmol/ l) to 12 g/ dl (7.5 mmol/ l).
|
Doxorubicin hydrochloride is suspected to cause serious birth defects when administered during pregnancy.
|
99.26 -0.65
|
Batch:
|
4.5 Interaction with other medicinal products and other forms of interaction
|
Each capsule contains 40 mg duloxetine (as hydrochloride).
|
Store in a refrigerator.
|
From a microbiological point of view, the product should be used immediately after dilution.
|